All products / DC20118
CAT. NO. DC20118
GZD856
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $800 USDRequest a quote / confirm availability → |
| 250 mg | $1,450 USDRequest a quote / confirm availability → |
| 1 g | $2,800 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
GZD856 is a novel and orally bioavailable PDGFRα/β inhibitor with IC50s of 68.6 and 136.6 nM, respectively. Anti-lung cancer activities. Also a Bcr-AblT315I inhibitor with IC50s of 19.9 and 15.4 nM for Bcr-Abl and T315I mutant.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC20118 |
|---|---|
| Product name | GZD856 |
| CAS | 1257628-64-0 |
| Molecular formula | C29H27F3N6O |
| Molecular weight | 532.559496164322 |
| Purity | >98% |
| SMILES | Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — GZD856 (DC20118)